These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6822375)

  • 1. Cyanidanol: will a hepatotrophic drug from Europe go west?
    Hepatology; 1983; 3(1):121-3. PubMed ID: 6822375
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ; Borg R
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract]   [Full Text] [Related]  

  • 3. (+)-cyanidanol-3.
    Lancet; 1982 Mar; 1(8271):549. PubMed ID: 6120400
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A contribution as to the effect of (+)-Cyanidanol-3 in chronic liver disease (author's transl)].
    Sondern W; Leube G
    Med Klin; 1978 Oct; 73(41):1432-6. PubMed ID: 703670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M; Kisfaludy S; Szalay F
    Acta Physiol Hung; 1984; 64(3-4):455-60. PubMed ID: 6397971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of (+)-cyanidanol-3 on chronic liver injury.
    Kovách G; Salamon F
    Acta Physiol Hung; 1984; 64(3-4):443-8. PubMed ID: 6152368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of (+)-cyanidanol-3.
    Lancet; 1982 Mar; 1(8274):737. PubMed ID: 6122024
    [No Abstract]   [Full Text] [Related]  

  • 9. [What is certain in the therapy of hepatocellular diseases with cyanidanol?].
    Schomerus H
    Internist (Berl); 1983 Dec; 24(12):684-9. PubMed ID: 6363332
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the molecular mechanism of action of (+)-cyanidanol-3 (author's transl)].
    Hennings G
    Arzneimittelforschung; 1979; 29(5):720-4. PubMed ID: 387044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A; Horváth T; Beró T; Kádas I; Pakodi F; Jávor T
    Acta Physiol Hung; 1984; 64(3-4):449-54. PubMed ID: 6152369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.
    Perrissoud D
    Prog Clin Biol Res; 1986; 213():559-69. PubMed ID: 3520595
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatoprotective agents in alcoholic liver disease.
    Morgan MY
    Acta Med Scand Suppl; 1985; 703():225-33. PubMed ID: 3937442
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats].
    Siegers CP
    Z Gastroenterol; 1982 Dec; 20(12):757-8. PubMed ID: 7164529
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L; Dávid K; Nagy I; Stotz G; Kelemen JT
    Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of therapy in chronic liver diseases. Double-blind study with cianidanol].
    Machalke K; Müller B
    Fortschr Med; 1982 Apr; 100(14):665-7. PubMed ID: 6123478
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of (+)-cyanidanol-3 on receptor activity of lymphocytes and hepatocytes and on hepatocyte-lymphocyte conjugation in alcoholic liver disease.
    Sipos J; Gabor V; Toth Z; Ribiczey P
    Int J Tissue React; 1984; 6(2):145-54. PubMed ID: 6203861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiments with a new drug in chronic liver diseases, especially alcohol-induced].
    Bel A; Chambon A
    Minerva Dietol Gastroenterol; 1977; 23(3):243-8. PubMed ID: 372846
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
    Bar-Meir S; Halpern Z; Gutman M; Shpirer Z; Baratz M; Bass D
    Gut; 1985 Sep; 26(9):975-9. PubMed ID: 3896964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.